Navigation Links
Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
Date:2/9/2011

CAMBRIDGE, Mass., Feb. 9, 2011 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by normalizing the immune response, presented results from preclinical studies with TRX518, a first-in-class immunomodulatory agent for the treatment of cancer. TRX518 is a monoclonal antibody reactive with the glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's anti-tumor response by enabling T cells to more effectively attack cancer cells. The preclinical data were presented as a poster and invited talk at the Keystone Symposia "Antibodies as Drugs" meeting held in Keystone, Colorado. 

The presentation included a range of data from preclinical studies of TRX518 and details of the fully humanized TRX518 antibody. Results and data included:

  • A murine analog of TRX518 showed anti-tumor activity as a monotherapy and, when used as a combination therapy with standard chemotherapeutics, prevented the establishment of tumors, induced complete and partial remission of established tumors, and prolonged survival in animal models of human cancer.
  • The enhancement of the anti-tumor response afforded by anti-GITR combination therapy was shown to target specific immune responses, because these animal models were resistant to tumor re-challenge while other antigenically distinct tumors grew normally.
  • TRX518 blocked the interaction of GITR with its ligand, enhanced the cytotoxicity of natural human killer cells, downmodulated GITR on peripheral blood lymphocytes, did not induce appreciable cytokine release, and was well tolerated and safe at high doses in non-human primates.
  • Characterization of the TRX518 human clinical candidate, a fully humanized Fc-disabled anti-human GITR IgG1 mAb.  

Based on these data, a Phase 1, first-in-human, open label, dos
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
2. Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes
3. Tolerx Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes
4. Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting
5. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
6. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
7. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
8. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
9. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
10. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
11. Watson Presents Outlook for Continued Long Term Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... its common stock consisting of 1,475,506 shares to be ... by certain of its stockholders. In addition, Nevro expects ... up to an additional 590,202 shares of common stock ...
(Date:6/1/2015)... MENLO PARK, Calif. , June ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... clinical trial of  VAL-083  (dianhydrogalactitol) in patients with ... deadly form of human brain cancer. ...
(Date:6/1/2015)... 1, 2015 CEFALY Technology , the ... device specifically authorized for use prior to the onset ... new PET trial showing that the Cefaly device returns ... in migraine patients, namely the orbitofrontal cortex and rostral ... which is an imaging test of the brain, used a radioactive substance ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2
... 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... Company"), a leading manufacturer of medical dressings, medical ... PurCotton® products in China, today announced that the ... establish Shenzhen PurCotton E-Commerce Co., Ltd.("PurCotton E-Commerce"), aiming ...
... 29, 2011 Cardium Therapeutics (NYSE Amex: ... compliance plan designed to reestablish compliance with its exchange ... the acquisition of a revenue-generating nutraceutical business designed to ... matter, the Company announced the incorporation of MedPodium Health ...
Cached Medicine Technology:Winner Medical's PurCotton E-Commerce Sets Sail 2Winner Medical's PurCotton E-Commerce Sets Sail 3Winner Medical's PurCotton E-Commerce Sets Sail 4Cardium Provides Update on Exchange Listing and Related Business Matters 2Cardium Provides Update on Exchange Listing and Related Business Matters 3Cardium Provides Update on Exchange Listing and Related Business Matters 4Cardium Provides Update on Exchange Listing and Related Business Matters 5
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... (NAPW) honors Kathy Everette-Gaines as a 2015-2016 inductee ... She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more ... Chapters. , “I’m pleased to welcome Kathy into ...
(Date:6/1/2015)... June 02, 2015 Dr. ... SC-based Piedmont Physical Medicine & Rehabilitation, P.A., has ... benefits of stem cell therapy for knees, and ... cases preferred alternative to arthroscopy or knee joint ... practitioner of Neuromusculoskeletal, Vascular and Regenerative Medicine, writes ...
(Date:6/1/2015)... New York, New York (PRWEB) June 01, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) has amended the Case ... AbbVie, Inc.’s AndroGel testosterone gel. The Amended Order ... District of Illinois on May 29, 2015, directs the ... the Court by August 10, 2015 that outlines parameters ...
(Date:6/1/2015)... 01, 2015 The Delta Dental Foundation ... and organizations in Michigan, Ohio and Indiana for its ... Sept. 30, 2015 has been set. , Across the ... to organizations that specifically focus on children’s oral health ... oral health in adults. Each grant request will be ...
(Date:6/1/2015)... On May 14, 2015, the AFC/Doctors ... Cherry Creek Chamber of Commerce for the grand opening ... typically do not offer primary care services by appointment; ... Urgent Care staff to schedule family care procedures, such ... 7:30 p.m. the center hosted presidents, CEOs, and managers ...
Breaking Medicine News(10 mins):Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees 2Health News:New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Brighter Futures Community Grants Program Seeks to Help Fund Local Oral Health Programs 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2
... Honors its own Working Mothers Hurricane Heroes, ... the world,s leading provider of employer-sponsored child care,early ... that were,recently recognized as "100 Best Companies" by ... companies are clients of Bright Horizons,underscoring the critical ...
... , (Monday, October 27, 10:30 AM EST) ,The ... alternative to in-home inspections for identifying asthma and allergy ... of Missouri, Kansas City, MO, selected 50 adult subjects ... list of areas in their home using a disposable ...
... , #7720, PATIENTS, HOME PHOTOS HELP IDENTIFY ASTHMA TRIGGERS, ... in-home photography may be a more cost-effective alternative to ... from Truman Medical Center and the University of Missouri, ... asthma to take photos of a predetermined list of ...
... URAC,s Board of,Directors has approved quality standards ... and Property and Casualty Pharmacy Benefit,Management. The ... Pharmacy Quality,Management(R) suite of products., (LOGO: ... within this suite of programs were developed ...
... ENCINITAS, Calif., Oct. 28 Inspired by ... Feel Beautiful Plastic Surgery in,Encinitas and Carlsbad, ... that creates a more sensuous, sculpted, fit ... incorporates advanced,methods that shape surface contour to ...
... Florida Physicians Group, is Early Adopter in U.S., ... ("Global Med" or the "Company") (OTC Bulletin Board: ... that its Wyndgate Technologies(R) ("Wyndgate") division has,licensed its ... physician group in Brevard County, Florida. The system ...
Cached Medicine News:Health News:Bright Horizons Congratulates 76 Clients Named to Working Mother's 100 Best 2Health News:New research about chronic lung disease presented at CHEST 2008 2Health News:New research about chronic lung disease presented at CHEST 2008 3Health News:New research about chronic lung disease presented at CHEST 2008 4Health News:New research about chronic lung disease presented at CHEST 2008 5Health News:New research about chronic lung disease presented at CHEST 2008 6Health News:New research about chronic lung disease presented at CHEST 2008 7Health News:CHEST 2008: Featured abstracts 2Health News:CHEST 2008: Featured abstracts 3Health News:CHEST 2008: Featured abstracts 4Health News:CHEST 2008: Featured abstracts 5Health News:CHEST 2008: Featured abstracts 6Health News:CHEST 2008: Featured abstracts 7Health News:CHEST 2008: Featured abstracts 8Health News:CHEST 2008: Featured abstracts 9Health News:CHEST 2008: Featured abstracts 10Health News:CHEST 2008: Featured abstracts 11Health News:CHEST 2008: Featured abstracts 12Health News:CHEST 2008: Featured abstracts 13Health News:CHEST 2008: Featured abstracts 14Health News:CHEST 2008: Featured abstracts 15Health News:CHEST 2008: Featured abstracts 16Health News:CHEST 2008: Featured abstracts 17Health News:CHEST 2008: Featured abstracts 18Health News:URAC Introduces New Pharmacy Benefit Management Accreditation for Workers' Compensation and Property and Casualty Programs 2Health News:New Tummy Tuck Technique Increases Sensuality 2Health News:Global Med Technologies(R), Inc. Implements Transfusion Management System in Large Private Physician Owned Laboratory 2Health News:Global Med Technologies(R), Inc. Implements Transfusion Management System in Large Private Physician Owned Laboratory 3Health News:Global Med Technologies(R), Inc. Implements Transfusion Management System in Large Private Physician Owned Laboratory 4
This EIA microplate opens new perspectives in the direct detection of Chlamydia. The choice of microplate immunoenzymatic technology and the use of a monoclonal antibody result in a combination of c...
... of rubella IgG antibody in women prior ... from possible rubella viral infection during pregnancy. ... greatly reduced the incidence of rubella epidemics, ... monitoring of immune status, especially for women ...
... Demonstration of rubella IgG antibody in women ... protection from possible rubella viral infection during ... has greatly reduced the incidence of rubella ... accurate monitoring of immune status, especially for ...
... Every Bard BrachyStar® Needle is designed ... an efficient and clinically effective brachytherapy procedure. ... featuring ultra-sharp tips and polished surfaces for ... of needle configurations and sizes assures an ...
Medicine Products: